Samil Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samil Pharmaceutical Co., Ltd. with three other
companies in this sector in South Korea:
Hwail Pharmaceutical Company Limited
sales of 106.13 billion Korean Won [US$94.35 million]
CKD Bio Corp
(106.69 billion Korean Won [US$94.85 million]
of which 100%
was Pharmaceutical Manufacturing), and
Yuyu Pharma Incorporated
(62.82 billion Korean Won [US$55.84 million]
Samil Pharmaceutical Co., Ltd. reported sales of 88.14 billion Korean Won (US$78.35 million)
December of 2015.
increase of 3.1%
versus 2014, when the company's sales were 85.46 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2013, when Samil Pharmaceutical Co., Ltd.
reported sales of 89.23 billion Korean Won.